We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current BOT market cap is 740.31M. The company's latest EPS is AUD -0.0088 and P/E is -53.41.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 7.56M | 6.88M | 2.75M | 3.77M | 2.07M |
| Operating Income | -16.7M | -3.39M | -13.19M | -9.13M | -13.99M |
| Net Income | -16.73M | -3.33M | -13.17M | -9.15M | -13.87M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 25.31M | 21.95M | 14.04M | 24.84M | 112.47M |
| Total Liabilities | 1.67M | 1.15M | 5.89M | 1.89M | 3.73M |
| Total Equity | 23.64M | 20.8M | 8.15M | 22.95M | 108.73M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -17.36M | -2.97M | -11.19M | -12.07M | -8.13M |
| Investing | -151k | -8k | -2.92M | -7.05M | -18M |
| Financing | 37.31M | -126k | -152k | 22.03M | 95.1M |
| Market Cap | 740.31M |
| Price to Earnings Ratio | -53.41 |
| Price to Sales Ratio | 361.54 |
| Price to Cash Ratio | 9.34 |
| Price to Book Ratio | 6.81 |
| Dividend Yield | - |
| Shares Outstanding | 1.58B |
| Average Volume (1 week) | 8.67M |
| Average Volume (1 Month) | 6.02M |
| 52 Week Change | 161.11% |
| 52 Week High | 0.505 |
| 52 Week Low | 0.1625 |
| Spread (Intraday) | 0.01 (1.05%) |
| Company Name | Botanix Pharmaceuticals Limited |
| Address |
suite 3 perth, western australia 6005 |
| Website | https://www.botanixpharma.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
